TY - JOUR
T1 - Clinical isolates of shiga toxin 1a-producing Shigella flexneri with an epidemiological link to recent travel to hispañiola
AU - Gray, Miranda D.
AU - Lampel, Keith A.
AU - Strockbine, Nancy A.
AU - Fernandez, Reinaldo E.
AU - Melton-Celsa, Angela R.
AU - Maurelli, Anthony T.
N1 - Publisher Copyright:
© 2014, Emerging Infectious Diseases. All rights reserved.
PY - 2014/10/1
Y1 - 2014/10/1
N2 - Shiga toxins (Stx) are cytotoxins involved in severe human intestinal disease. These toxins are commonly found in Shigella dysenteriae serotype 1 and Shiga-toxin-producing Escherichia coli; however, the toxin genes have been found in other Shigella species. We identified 26 Shigella flexneri serotype 2 strains isolated by public health laboratories in the United States during 2001-2013, which encode the Shiga toxin 1a gene (stx1a). These strains produced and released Stx1a as measured by cytotoxicity and neutralization assays using anti-Stx/Stx1a antiserum. The release of Stx1a into culture supernatants increased ≈100-fold after treatment with mitomycin C, suggesting that stx1a is carried by a bacteriophage. Infectious phage were found in culture supernatants and increased ≈1,000-fold with mitomycin C. Whole-genome sequencing of several isolates and PCR analyses of all strains confirmed that stx1a was carried by a lambdoid bacteriophage. Furthermore, all patients who reported foreign travel had recently been to Hispañiola, suggesting that emergence of these novel strains is associated with that region.
AB - Shiga toxins (Stx) are cytotoxins involved in severe human intestinal disease. These toxins are commonly found in Shigella dysenteriae serotype 1 and Shiga-toxin-producing Escherichia coli; however, the toxin genes have been found in other Shigella species. We identified 26 Shigella flexneri serotype 2 strains isolated by public health laboratories in the United States during 2001-2013, which encode the Shiga toxin 1a gene (stx1a). These strains produced and released Stx1a as measured by cytotoxicity and neutralization assays using anti-Stx/Stx1a antiserum. The release of Stx1a into culture supernatants increased ≈100-fold after treatment with mitomycin C, suggesting that stx1a is carried by a bacteriophage. Infectious phage were found in culture supernatants and increased ≈1,000-fold with mitomycin C. Whole-genome sequencing of several isolates and PCR analyses of all strains confirmed that stx1a was carried by a lambdoid bacteriophage. Furthermore, all patients who reported foreign travel had recently been to Hispañiola, suggesting that emergence of these novel strains is associated with that region.
UR - http://www.scopus.com/inward/record.url?scp=84907288847&partnerID=8YFLogxK
U2 - 10.3201/eid2010.140292
DO - 10.3201/eid2010.140292
M3 - Article
C2 - 25271406
AN - SCOPUS:84907288847
SN - 1080-6040
VL - 20
SP - 1669
EP - 1677
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 10
ER -